Julius Clinical is a global Academic CRO with a distinct focus on supporting the development of drugs that provide a significant improvement of medical practise. We offer end-to-end CRO and SMO services to run global clinical trials, which are supported by our proprietary scientific, clinical trial site networks and tailor-made operational solutions. Our track record in running vaccines clinical trials is based on the successful execution of a vaccination trial in approximately 85,000 subjects aged 65 years and older (CAPiTA study) and has expanded ever since with various Phase II and III vaccination studies for influenza, RSV and long term follow up and monitoring for COVID-19 vaccinations .
As a result of our academic and medical roots, science is at the heart of everything we do. We work closely together with recognised academic leaders actively involved in the design, execution, and interpretation of clinical trials. Because of this scientific expertise and our operational excellence, we are uniquely equipped to assist in providing answers for today’s clinical drug development challenges.